Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00077831 · ClinicalTrials.gov registry record
Child and Infant Learning Project
A clinical trial, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- 535
- Enrollment target
NCT00077831: Completed study, sponsored by Seattle Children's Hospital.
NCT00077831 is a clinical trial that has completed, run by Seattle Children's Hospital. The registered enrollment target is 535 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00077831 has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- 535 participants
- Enrollment target
Study Summary
To learn more about the cognitive and motor development of infants and young children born with a craniofacial defect called craniosynostosis.
Interventions
- BEHAVIORAL neurobehavioral development
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 535 participants |
| Start Date | 2001-09 |
| Est. Completion | 2015-06 |
What the finished NCT00077831 record still lists
NCT00077831 is an observational study that tracks outcomes without assigning an intervention. The registered 535 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which neurobehavioral development is the first listed.
NCT00077831 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00077831 about?
NCT00077831 is a clinical study titled "Child and Infant Learning Project". To learn more about the cognitive and motor development of infants and young children born with a craniofacial defect called craniosynostosis.
What is the current status of trial NCT00077831?
This trial is currently completed. The enrollment target is 535 participants. The study started on 2001-09. Estimated completion is 2015-06.
What interventions are being tested in trial NCT00077831?
The interventions under investigation include: neurobehavioral development (BEHAVIORAL).
Who is sponsoring clinical trial NCT00077831?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05614739 · 535 participants · Phase 1
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
- NCT07091617 · 535 participants · NA
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
- NCT04910685 · 534 participants · Phase 2
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
- NCT06128551 · 534 participants · Phase 1
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia